Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michaela Luconi

Showing results (91-100 of 107) with videos related to

Pageof 11
Sort By:
Frontiers in Endocrinology|January 25, 2024
Hypogonadism and sexual function in men affected by adrenocortical carcinoma under mitotane therapyLetizia Canu, Clotilde Sparano, Lara Naletto, et al.
Scientific Reports|July 16, 2017
Evaluation and diagnostic potential of circulating extracellular vesicle-associated microRNAs in adrenocortical tumorsPál Perge, Henriett Butz, Raffaele Pezzani, et al.
Scientific Reports|April 5, 2024
The 3D in vitro Adrenoid cell model recapitulates the complexity of the adrenal glandSerena Martinelli, Giulia Cantini, Arianna Pia Propato, et al.
Journal of Personalized Medicine|November 27, 2021
Stimulated Expression of CXCL12 in Adrenocortical Carcinoma by the PPARgamma Ligand Rosiglitazone Impairs Cancer ProgressionGiulia Cantini, Laura Fei, Letizia Canu, et al.
Cancers|March 11, 2020
Glutaminases as a Novel Target for SDHB-Associated Pheochromocytomas/ParagangliomasBalazs Sarkadi, Katalin Meszaros, Ildiko Krencz, et al.
The Journal of Clinical Endocrinology and Metabolism|September 3, 2020
RNA Sequencing and Somatic Mutation Status of Adrenocortical Tumors: Novel Pathogenetic InsightsGuido Di Dalmazi, Barbara Altieri, Claus Scholz, et al.
International Journal of Cancer|March 27, 2023
FSCN1 as a new druggable target in adrenocortical carcinomaCarmen Ruggiero, Mariangela Tamburello, Elisa Rossini, et al.
Cancers|March 19, 2020
Cancer-testis Antigen FATE1 Expression in Adrenocortical Tumors Is Associated with A Pervasive Autoimmune Response and Is A Marker of Malignancy in Adult, but Not Children, ACCMabrouka Doghman-Bouguerra, Pascal Finetti, Nelly Durand, et al.
International Journal of Molecular Sciences|December 9, 2023
High Filamin a Expression in Adrenocortical Carcinomas Is Associated with a Favourable Tumour Behaviour: A European Multicentric StudyRosa Catalano, Barbara Altieri, Anna Angelousi, et al.
The Journal of Clinical Endocrinology and Metabolism|September 16, 2017
Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical CarcinomaSilviu Sbiera, Iuliu Sbiera, Carmen Ruggiero, et al.
Pageof 11

Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
Frontiers in Endocrinology|January 25, 2024
Hypogonadism and sexual function in men affected by adrenocortical carcinoma under mitotane therapyLetizia Canu, Clotilde Sparano, Lara Naletto, et al.
Scientific Reports|July 16, 2017
Evaluation and diagnostic potential of circulating extracellular vesicle-associated microRNAs in adrenocortical tumorsPál Perge, Henriett Butz, Raffaele Pezzani, et al.
Scientific Reports|April 5, 2024
The 3D in vitro Adrenoid cell model recapitulates the complexity of the adrenal glandSerena Martinelli, Giulia Cantini, Arianna Pia Propato, et al.
Journal of Personalized Medicine|November 27, 2021
Stimulated Expression of CXCL12 in Adrenocortical Carcinoma by the PPARgamma Ligand Rosiglitazone Impairs Cancer ProgressionGiulia Cantini, Laura Fei, Letizia Canu, et al.
Cancers|March 11, 2020
Glutaminases as a Novel Target for SDHB-Associated Pheochromocytomas/ParagangliomasBalazs Sarkadi, Katalin Meszaros, Ildiko Krencz, et al.
The Journal of Clinical Endocrinology and Metabolism|September 3, 2020
RNA Sequencing and Somatic Mutation Status of Adrenocortical Tumors: Novel Pathogenetic InsightsGuido Di Dalmazi, Barbara Altieri, Claus Scholz, et al.
International Journal of Cancer|March 27, 2023
FSCN1 as a new druggable target in adrenocortical carcinomaCarmen Ruggiero, Mariangela Tamburello, Elisa Rossini, et al.
Cancers|March 19, 2020
Cancer-testis Antigen FATE1 Expression in Adrenocortical Tumors Is Associated with A Pervasive Autoimmune Response and Is A Marker of Malignancy in Adult, but Not Children, ACCMabrouka Doghman-Bouguerra, Pascal Finetti, Nelly Durand, et al.
International Journal of Molecular Sciences|December 9, 2023
High Filamin a Expression in Adrenocortical Carcinomas Is Associated with a Favourable Tumour Behaviour: A European Multicentric StudyRosa Catalano, Barbara Altieri, Anna Angelousi, et al.
The Journal of Clinical Endocrinology and Metabolism|September 16, 2017
Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical CarcinomaSilviu Sbiera, Iuliu Sbiera, Carmen Ruggiero, et al.
Pageof 11